Tvardi Therapeutics, Inc. financial statements
Tvardi Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 18.21M | 10-K |
| Cash and equivalents | USD 20.73M | 10-Q |
| Total debt | USD 201K | EODHD |
Tvardi Therapeutics, Inc. financials on 6ix · Tvardi Therapeutics, Inc. on 6ix